Evidence map›Paper›PMID 26792279›Full record

ReviewDigestive diseases and sciences2016

Mucin-Microbiota Interaction During Postnatal Maturation of the Intestinal Ecosystem: Clinical Implications.

Sana Rokhsefat, Aifeng Lin, Elena M Comelli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Digestive diseases and sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Relationship between pathogenicFrontiers in cellular and infection microbiology · 2024
    Article
  8. Article
  9. Drug-Induced Enterocolitis Syndrome in Children.International journal of molecular sciences · 2023
    Review
  10. Review
  11. Review
  12. Colon mucus in colorectal neoplasia and beyond.World journal of gastroenterology · 2022
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Microorganisms · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sana RokhsefatDepartment of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building Room 308a, 150 College Street, Toronto, ON, M5S3E2, Canada.
Aifeng LinDepartment of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building Room 308a, 150 College Street, Toronto, ON, M5S3E2, Canada.
Elena M ComelliDepartment of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building Room 308a, 150 College Street, Toronto, ON, M5S3E2, Canada. elena.comelli@utoronto.ca.ORCID 0000-0002-5201-5437
University of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mucus layer and gut microbiota interplay contributes to host homeostasis. The mucus layer serves as a scaffold and a carbon source for gut microorganisms; conversely, gut microorganisms, including mucin degraders, influence mucin gene expression, glycosylation, and secretion. Conjointly they shield the epithelium from luminal pathogens, antigens, and toxins. Importantly, the mucus layer and gut microbiota are established in parallel during early postnatal life. During this period, the development of gut microbiota and mucus layer is coupled with that of the immune system. Developmental changes of different mucin types can impact the age-dependent patterns of intestinal infection in terms of incidence and severity. Altered mucus layer, dysbiotic microbiota, and abnormal mucus-gut microbiota interaction have the potential for inducing systemic effects, and accompany several intestinal diseases such as inflammatory bowel disease, colorectal cancer, and radiation-induced mucositis. Early life provides a pivotal window of opportunity to favorably modulate the mucus-microbiota interaction. The support of a health-compatible mucin-microbiota maturation in early life is paramount for long-term health and serves as an important opportunity for clinical intervention.

Indexed as

AnimalsHumansInfantInfant, NewbornIntestinesMicrobiotaMucinsMucinsGut microbiotaIntestinal barrierMucinPostnatal maturation

Identifiers

PMID26792279
OpenAlexW2288329334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.